Shreeram Aradhye Dicerna Pharmaceuticals Inc (DRNA) insider trading activity

Shreeram Aradhye is EVP & Chief Medical Officer of Dicerna Pharmaceuticals Inc. Currently has a direct ownership of 0 shares of DRNA, which is worth approximately $0. The most recent transaction as insider was on Dec 28, 2021, when has been sold 6,973 shares (Common Stock) at a price of $38.25 per share, resulting in proceeds of $266,717. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Shreeram Aradhye Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 28 2021	SELL Disposition due to a tender of shares in a change of control transaction	$266,717 $38.25 p/Share	6,973 Reduced 100.0%	0 Common Stock
Dec 15 2021	SELL Payment of exercise price or tax liability	$31,696 $38.05 p/Share	833 Reduced 10.67%	6,973 Common Stock
Dec 15 2021	BUY Exercise of conversion of derivative security	-	2,837 Added 26.66%	7,806 Common Stock
Sep 17 2021	SELL Open market or private sale	$44,142 $21.47 p/Share	2,056 Reduced 29.27%	4,969 Common Stock
Sep 15 2021	BUY Exercise of conversion of derivative security	-	7,025 Added 50.0%	7,025 Common Stock

Also insider at

AXLA

Axcella Health Inc. Healthcare

Director